Marlowe Reports Growth and Strategic Divestment Results
Company Announcements

Marlowe Reports Growth and Strategic Divestment Results

Marlowe (GB:MRL) has released an update.

Marlowe PLC has announced its preliminary unaudited results for the fiscal year ended March 31, 2024, with revenue up by 8% to £503.2 million and a focus on Testing, Inspection & Certification (TIC) and Occupational Health markets. Despite an increase in revenue, the company reported a statutory loss before tax of £10.9 million, attributed to higher finance costs and one-off expenses related to acquisitions and restructuring. Following a strategic review, Marlowe has completed a significant divestment and is returning capital to shareholders through dividends and a share buy-back program.

For further insights into GB:MRL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskMarlowe Unveils Optima Health Demerger Plan
TipRanks UK Auto-Generated NewsdeskMarlowe PLC Completes Share Buyback Program
TipRanks UK Auto-Generated NewsdeskMarlowe PLC Proceeds with Share Buyback Plan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App